AmLactin® Sheds Its Skin to Reveal a Fresh, New Look
MAPLE GROVE, Minn., March 19, 2012 /PRNewswire/ -- AmLactin®, the #1 moisturizer brand recommended by dermatologists for rough, dry skin, is donning a fresh, new look while bringing dry skin sufferers the same effective, hard-working formulas. The makeover comes with a new family name: AmLactin® Alpha-Hydroxy Skin Care. The contemporary design graces white, pearlescent bottles and tubes complemented by a series of vibrant colors and a signature droplet to convey the line's intensity and success at helping skin retain its moisture.
To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/55256-amlactin-alpha-hydroxy-skin-care-moisturizer
(Photo: http://photos.prnewswire.com/prnh/20120319/MM71646 )
"We have transformed the AmLactin® packaging to convey a contemporary look and feel that appeals to women interested in beautifying their dry skin," said Jim Hughes, Vice President, Marketing at Upsher-Smith Laboratories, Inc. "Our goal is to attract 21st century women seeking innovative skin care solutions while maintaining our scientific heritage as a serious, intense moisturizer."
AmLactin® Alpha-Hydroxy Skin Care includes AmLactin® Moisturizing Body Lotion, AmLactin® Ultra Hydrating Body Cream for severe dry skin and AmLactin® Foot Cream. All three products contain alpha-hydroxy acid (AHA) moisturizers, which are effective at exfoliating and hydrating the skin. AmLactin® formulas also contain emollients and humectants that help retain the skin's natural moisture and draw water to the skin so it looks and feels soft and smooth. AmLactin® is available in a variety of sizes and formulas to meet the varying moisturizing needs of women. They include:
- AmLactin® Moisturizing Body Lotion - an everyday body lotion for rough, dry skin. It is specially formulated with clinically proven 12 percent lactic acid and is pH-balanced for the skin to gently encourage natural skin cell renewal through exfoliation, creating a soft, smooth texture. It is available in four sizes:
- 7.9 ounce bottle with press-cap
- 14.1 ounce bottle with pump
- 17.6 ounce bonus bottle with pump (seasonal)
- 20 ounce bonus size only available at Costco
- AmLactin® Ultra Hydrating Body Cream (formerly AmLactin XL ®) - specially formulated for severe, persistently dry skin areas that need extra attention. It contains the patented ULTRAPLEX® formula that gently exfoliates and is clinically proven to intensely hydrate for long-lasting moisture. With rich humectants and creamy emollients, AmLactin® Ultra provides serious relief and is available in a 4.9 ounce tube with a flip-top cap.
- AmLactin® Foot Cream - a clinical-strength foot cream for rough, dry, and callused feet. AmLactin® Foot Cream contains the premium triple-action, alpha-hydroxy therapy with the clinically proven, intensely hydrating ULTRAPLEX® formula and comes in a 3 ounce easy-to-carry, easy-to-store travel-size tube with a flip-top cap.
AmLactin® Alpha-Hydroxy Skin Care transitions into stores this month. AmLactin® products are available without a prescription at Costco, Walmart, Walgreens, CVS, Rite-Aid, www.drugstore.com and other fine retailers nationwide. For more information, visit the NEW www.amlactin.com where you can download valuable coupons and search the store locator to find a store where AmLactin® can be purchased.
Upsher-Smith
Upsher-Smith Laboratories, Inc. is a privately held, U.S.-based company devoted to improving health and advancing wellness since 1919. Upsher-Smith demonstrates its commitment to meeting the healthcare needs of its customers through developing, producing and marketing consumer and prescription products. In addition to its strong heritage in generics, Upsher-Smith's branded businesses focus on women's health, dermatology and CNS therapeutic areas. For additional information, visit http://www.upsher-smith.com.
SOURCE Upsher-Smith Laboratories, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article